Back
EACVI Premium Access

Late gadolinium enhancement in patients with hypertrophic cardiomyopathy: correlation with phenotypic and functional heart parameters

Session: Poster session 5 - Cross-Modality and Multi-Modality Imaging Topics
Topic: Imaging of Myocardial Disease
Speaker: Associate Professor N. Krylova (Moscow, RU)
Event: EuroEcho-Imaging 2018

Congress Presentation

About the speaker

Associate Professor Natalia Krylova

Pirogov Russian National Research Medical University , Moscow (Russian Federation)
0 follower

12 more presentations in this session

Right ventricular to pulmonary circulation uncoupling is associated with reduced stroke volume reserve and worse exercise performance in patients with heart failure

Speaker: Doctor A. Giammarresi (Bergamo, IT)

Access
Abstract
Slides
Thumbnail

Phenotyping right ventricular contractile reserve in patients with heart failure with preserved ejection fraction of different etiology

Speaker: Doctor V. Labate (San Donato Milanese, IT)

Access
Abstract
Slides
Thumbnail

The impact of flow-tissue interaction in heart failure patients during biventricular pacing: a particle image velocimetry and speckle tracking acute study

Speaker: Doctor P. Caso (Naples, IT)

Access
Abstract
Thumbnail

Mitral effective regurgitant orifice area in acute decompensated heart failure: clinical correlates and mid-term prognostic implication.

Speaker: Doctor F. Bulian (Conegliano, IT)

Access
Abstract
Thumbnail

Prognostic significance and pathophysiological insights of abnormal VO2/WR relationship in heart failure patients

Speaker: Doctor A. Giammarresi (Bergamo, IT)

Access
Abstract
Slides
Thumbnail

Access the full session

Poster session 5 - Cross-Modality and Multi-Modality Imaging Topics

Speakers: Associate Professor N. Krylova, Doctor A. Giammarresi, Doctor V. Labate, Doctor P. Caso, Doctor F. Bulian...
Access
Thumbnail

About the event

Image

EuroEcho-Imaging 2018

5 December - 8 December 2018

Sessions Presentations

Congress
logo Image

ESC 365 is supported by

logo Novo Nordisk
logo Bristol Myers Squibb